Opens in a new tab

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment.

Detailed Description

SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows for the detection, annotation, and pre‑classification of genomic variants from complex NGS data, facilitating decision‑making in oncology, rare diseases, and hereditary disorders.

SOPHiA DDM Platform

Principle of operation

SOPHiA DDM® is a web‑based platform powered by artificial intelligence designed for genomic data analysis, automatically performing quality control, alignment, and variant detection. It then executes a comprehensive variant annotation from multiple sources and pre‑classifies them into different pathogenicity categories. The platform facilitates interpretation through integrated databases and allows the generation of custom variant reports.

SOPHiA DDM principle of operation

Clinical applications

It is aimed at genomic analysis in oncology, rare diseases, and hereditary disorders. The platform is designed to facilitate rapid and confident decision‑making through the detection, annotation, and pre‑classification of genomic variants.

Benefits

In genomics, the platform helps overcome bottlenecks by:

Seamless integration of clinical genomics workflows, reducing operational barriers thanks to its web access, single workspace, and new interface. Prioritisation of variants, simplification of interpretation, and acceleration of reporting. AI and machine learning algorithms aimed at increasing positive findings and improving confidence in the analysis of complex variants.

Intended user / audience

Solution aimed at clinical genomics laboratories, healthcare institutions, and precision medicine teams that need to integrate genomic analysis workflows in areas such as oncology, rare diseases, and hereditary disorders, with the ability to work in IVD or RUO environments depending on the application and the corresponding mode of use.

Key Features

SaaS platform for clinical genomic analysis based on artificial intelligence Automatic detection, annotation and pre‑classification of genetic variants Integration with multiple databases for proper management of identified variants Generation of customised and clinically actionable reports Access to a global community of genomics experts High security and data encryption in compliance with international regulations Intuitive and easy‑to‑use interface with fast response time
×

Area:

Molecular Genetics, Software, Software solutions for germline analysis

Technology:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

FUSIONPlex™ Heme v3 & Pan-Heme v2

RNA-based next-generation sequencing solution for the analytically sensitive identification of known and novel gene fusions, splicing variants, exon-skipping events, SNVs/Indels and gene expression in haematological malignancy research. FUSIONPlex Pan-Heme v2 provides broad coverage of 218 genes associated with haematological malignancies, while FUSIONPlex Heme v3 provides more focused coverage of 121 genes targeting alterations frequently found…
Archer Dx
Next Generation Sequencing (NGS)

Tapestri™

Short description The Tapestri® platform enables the simultaneous integration of three biological dimensions from the same individual cell: DNA, RNA and surface proteins. This unprecedented multi-omics capability provides a direct and functional view of how specific genetic alterations (genotype) shape transcriptional expression and protein behaviour (phenotype), without the need to reconcile data from separate platforms.…
Mission Bio
Single cell Sequencing

Violet 3.0 & QF-Pro® Technology

Conventional spatial biology reveals where proteins are; Violet 3.0 and QF-Pro® technology reveal what they are doing. Most current proteomic assays are limited to measuring molecular expression levels, overlooking whether proteins are actually activated or interacting with one another. In critical fields such as immuno-oncology, neurobiology and drug development, the relationship between expression and the…
Hawk Biosystem
Functional Assay

Beacon® Optofluidic Suite

The Beacon® Optofluidic Suite represents an absolute revolution in cell biology and biotherapeutic development. By synergistically integrating advanced microfluidics, precision optics, optoelectronics and artificial intelligence, this platform enables the isolation, culture, characterization and recovery of thousands of individual cells in a fully automated manner and in real time. Unlike traditional static or destructive methodologies, Bruker’s…
Bruker
Functional Assay